Newborns Supplemented With Gentle-UHT Donor Milk
Neonates Supplemented With Gentle-UHT Donor Human Milk in the First Week of Life
1 other identifier
interventional
31
1 country
1
Brief Summary
This study evaluates the effects of providing breastfeeding mothers with Gentle-UHT donor human milk (GHM) after discharge to bridge the gap during delayed onset lactation, to support an exclusive human milk diet and continued breastfeeding through the infant's first week of life. The investigators aim to determine the safety of GHM, and if GHM provided to breastfeeding mothers of outpatient babies with early weight loss will ensure babies adequately gain weight according to age-matched controls.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 3, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 17, 2020
CompletedFirst Submitted
Initial submission to the registry
July 23, 2020
CompletedFirst Posted
Study publicly available on registry
July 30, 2020
CompletedJuly 30, 2020
July 1, 2020
6 months
July 23, 2020
July 29, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Weight gain
Average weights compared to WHO data
8-9 days of life
Secondary Outcomes (1)
Exclusive human milk diet
8-9 days of life
Study Arms (1)
Supplementation of Gentle-UHT donor milk
EXPERIMENTALSupplementation of Gentle-UHT donor milk in addition to mother's own milk, as recommended by the health care providers.
Interventions
Providers referred mothers with newborns that fit the following criteria: exhibited insufficient milk supply, an infant with early weight loss born \>36 weeks gestation. Mother was given Gentle-UHT donor milk for supplementation, in addition to mother's own milk for the first week of the infant's life after hospital discharge.
Eligibility Criteria
You may qualify if:
- Gestational age \>36 weeks
- Exclusively fed human milk
- Age \<96 hours (4 days)
You may not qualify if:
- Previous admittance to the neonatal intensive care unit
- Supplementation of any formula
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- LactaLogics, Inclead
- Renown Regional Medical Centercollaborator
Study Sites (1)
LactaLogics, Inc.
Port Saint Lucie, Florida, 34952, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rebecca Perry, MD
Renown Regional Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 23, 2020
First Posted
July 30, 2020
Study Start
August 3, 2018
Primary Completion
January 31, 2019
Study Completion
January 17, 2020
Last Updated
July 30, 2020
Record last verified: 2020-07
Data Sharing
- IPD Sharing
- Will not share